Company intelligence / Profile preview

Kaifeng Pharmaceutical Group Co., Ltd

Zhengzhou, Henan, Chinakfmryy.com ↗

Ownership: Private
Development stage: Other

Overview

Established in May 1949, produces APIs and formulations including doxycycline, gentamicin sulfate, and recombinant coagulation factors. Mingren subsidiary (founded 2002) specializes in sterile manufacturing with annual API capacity >300MT.

Therapeutic areas: HematologyPulmonologyPsychiatryInfectious Diseases
Modalities: Small molecule drugsRecombinant proteinsPolypeptide APIsSterile APIs
Industry: Biotech

Partnerships

Gensciences(co-development partner for Factor VIII-Fc fusion protein)

Beyond the preview

Go deeper on Kaifeng Pharmaceutical Group Co., Ltd.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kaifeng Pharmaceutical Group Co., Ltd.